Literature DB >> 19254495

In vitro evaluation of the viability of vaginal cells (VK2/E6E7) and probiotic Lactobacillus species in lemon juice.

Kingsley C Anukam1, Gregor Reid.   

Abstract

BACKGROUND: Women, especially in developing countries, most often bear the brunt of HIV infections. The continued lack of viable vaccines and microbicides has made some women resort to using natural products such as lemon or lime juice to avoid infection. Few in vitro studies have been done on the effect of lemon juice on vaginal cells and lactobacilli that constitute the major microbiota in healthy women.
OBJECTIVE: The objective of the present study was to evaluate in vitro the effect of lemon juice on the viability of vaginal cells (VK2/E6E7) and vaginal Lactobacillus species.
METHODS: Vaginal cells were exposed to different concentrations (0-30%) of lemon juice at pH 2.3 and 4.5 for 10 min. Viability was determined by staining the cells with propidium iodide and analysing them by flow cytometry. Lactobacillus organisms were dispensed into microplates with vaginally defined medium + peptone (VDMP) containing different concentrations of lemon juice ranging from 0 to 100%.
RESULTS: Lemon juice at pH 2.3 had a significant (P = 0.03) toxic effect on the vaginal cell line used. At 30% concentration, the vaginal cells were practically non-viable, typified by a 95% loss of viability, whereas at pH 4.5 there was only 5% cell loss. Lemon juice had varying growth inhibitory effects on the Lactobacillus species tested. At pH 4.5 and using 10-30% lemon juice, there was a stimulatory growth effect on certain Lactobacillus species.
CONCLUSIONS: Lemon juice (20-30%) at pH 2.3 was highly toxic to VK2/E6E7 cells, and at pH 4.5 there was no significant effect on the viability of the cells within 10 min. Lemon juice above 10% at pH 2.3 was found to be detrimental to the growth of vaginal lactobacilli. Although lemon juice may be useful in other applications, its use in the vaginal region should be discouraged.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254495     DOI: 10.1071/sh08037

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  6 in total

1.  Different Host Immunological Response to C. albicans by Human Oral and Vaginal Epithelial Cells.

Authors:  Ying Gao; Guanzhao Liang; Qiong Wang; Xiaodong She; Dongmei Shi; Yongnian Shen; Xiaohong Su; Xiang Wang; Wenmei Wang; Dongmei Li; Weida Liu
Journal:  Mycopathologia       Date:  2019-01-01       Impact factor: 2.574

2.  Safety and anti-HIV assessments of natural vaginal cleansing products in an established topical microbicides in vitro testing algorithm.

Authors:  Carol S Lackman-Smith; Beth A Snyder; Katherine M Marotte; Mark C Osterling; Marie K Mankowski; Maureen Jones; Lourdes Nieves-Duran; Nicola Richardson-Harman; James E Cummins; Brigitte E Sanders-Beer
Journal:  AIDS Res Ther       Date:  2010-07-09       Impact factor: 2.250

3.  Effects of Female Sex Hormones on Susceptibility to HSV-2 in Vaginal Cells Grown in Air-Liquid Interface.

Authors:  Yung Lee; Sara E Dizzell; Vivian Leung; Aisha Nazli; Muhammad A Zahoor; Raina N Fichorova; Charu Kaushic
Journal:  Viruses       Date:  2016-08-30       Impact factor: 5.048

4.  Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.

Authors:  Andrew Vallely; Lisa Fitzgerald; Voletta Fiya; Herick Aeno; Angela Kelly; Joyce Sauk; Martha Kupul; James Neo; John Millan; Peter Siba; John M Kaldor
Journal:  BMC Res Notes       Date:  2012-11-01

5.  Transcytosis of HIV-1 through vaginal epithelial cells is dependent on trafficking to the endocytic recycling pathway.

Authors:  Ballington L Kinlock; Yudi Wang; Tiffany M Turner; Chenliang Wang; Bindong Liu
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

Review 6.  Has knowledge of the vaginal microbiome altered approaches to health and disease?

Authors:  Gregor Reid
Journal:  F1000Res       Date:  2018-04-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.